CD274 and neoplasm: Furthermore, to determine whether the tumor-suppressive effect of CC1-NPGY in vivo is specifically mediated through PD-L1 downregulation—rather than an immune response against the peptide itself—we generated a PD-L1 KO CT26 cell line using the CRISPR/Cas9 system.